STEMLINE THERAPEUTICS (STML) earnings
Quarterly and annual STML reports and results, each read against the price at its own news timestamp. Back to the STML overview →
No STML earnings events in the measured window.
Nothing matched in the current window — the STML overview has every event we measure for this name.
Get an email when STML moves on news →Keep exploring
More STML: analyst actions → · SEC filings → · STML overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Revance Therapeutics, Inc. (RVNC) | 701 | 0.00% | 42% |
| AB Corporate Bond ETF (EYEG) | 700 | 0.00% | 44% |
| REGENXBIO Inc. (RGNX) | 696 | +0.35% | 54% |
| ALDER BIOPHARMACEUTICALS INC (ALDR) | 693 | -0.21% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.